Ind-Swift Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Ind-Swift Laboratories has a total shareholder equity of ₹10.1B and total debt of ₹164.0M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are ₹11.9B and ₹1.8B respectively. Ind-Swift Laboratories's EBIT is ₹941.1M making its interest coverage ratio -7.5. It has cash and short-term investments of ₹4.4B.
Key information
1.6%
Debt to equity ratio
₹163.96m
Debt
| Interest coverage ratio | -7.5x |
| Cash | ₹4.38b |
| Equity | ₹10.12b |
| Total liabilities | ₹1.76b |
| Total assets | ₹11.88b |
Recent financial health updates
Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28
These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27Recent updates
There Are Some Reasons To Suggest That Ind-Swift Laboratories' (NSE:INDSWFTLAB) Earnings Are A Poor Reflection Of Profitability
Nov 20Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors
Oct 20Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company
Jul 02Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story
May 21Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Apr 13Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?
Feb 17We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings
Dec 30These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27Financial Position Analysis
Short Term Liabilities: INDSWFTLAB's short term assets (₹5.9B) exceed its short term liabilities (₹1.6B).
Long Term Liabilities: INDSWFTLAB's short term assets (₹5.9B) exceed its long term liabilities (₹121.3M).
Debt to Equity History and Analysis
Debt Level: INDSWFTLAB has more cash than its total debt.
Reducing Debt: INDSWFTLAB's debt to equity ratio has reduced from 188.2% to 1.6% over the past 5 years.
Debt Coverage: INDSWFTLAB's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: INDSWFTLAB earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 06:34 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ind-Swift Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hitesh Kuvelkar | First Global Stockbroking (P) Ltd. |